Lobe Sciences (OTCQB: LOBEF) (CSE: LOBE) is a life sciences company focused on developing sub-psychedelic doses of psychedelic medicines targeting the 5-HT2A receptor. The company, through collaborations with industry-leading partners, is engaged in drug research and development using psychedelic compounds in conjunction with NAC (N-acetyl cysteine) to improve brain and mental health and wellness. Phil Young, CEO will provide an overview, scientific focus & development plans for 2022 and beyond. For more information, visit the company’s website at www.lobesciencesir.com.
To view IBN’s virtual coverage of Investor Summit Group’s Q1 Virtual Event, visit https://ibn.fm/2022InvestorSummitQ1Portal
About InvestorBrandNetwork’s Virtual Coverage
The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the publicly traded companies participating virtually at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
